FDA Considers New Dupilumab Data for CSU Indication ...Middle East

Medscape - News
Additional phase 3 trial results confirmed improvement in hives and itching. Medscape Medical News

Hence then, the article about fda considers new dupilumab data for csu indication was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Considers New Dupilumab Data for CSU Indication )

Apple Storegoogle play

Last updated :

Also on site :